Delivery Order SPE2DR25D3501-SPE2DR26FM2LD
Award Date 1/14/26
Potential Completion Date 2/5/26
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $19.2K delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 7, 2026, for the supply of Revlimid 10 mg capsules in quantities of 28 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 29, 2026. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This delivery order, valued at $17,930.46, was awarded on January 8, 2026, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Revlimid 5 mg capsules (28-count packages). The contract is a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Revlimid 2.5 mg capsules (28-count packages) with a ceiling value of $14,450.99. This firm fixed-price delivery order, which is not set-aside designated, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical supplies will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Revlimid 2.5 mg capsules (28-count units) valued at $20,846.38 on January 7, 2026, with completion by January 29, 2026. This firm fixed-price contract represents a non-set-aside award issued under open competition. The order will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at approximately $82,043 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (100-count units) on January 13, 2026, with an ultimate completion date of February 4, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc.,...
- The Defense Logistics Agency awarded a delivery order valued at $25,840.56 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) under a firm fixed price contract. The award, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and will fulfill...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Revlimid 25 mg capsules (21-count unit) under a firm fixed-price contract with a ceiling value of $7,233.16. The order was competitively awarded without set-aside designation and is scheduled for completion by January 22, 2026. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global...
- The Defense Logistics Agency awarded a $51,089.97 delivery order to AmerisourceBergen Drug Corp for Revlimid 10 mg capsules (28-count) on September 9, 2025, with performance completion targeted for September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Revlimid 10 mg capsules (28-count package) with a ceiling value of $102,180.00. This firm fixed-price delivery order, which is expected to be completed by September 17, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a $1.34 million delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Revlimid 10 mg capsules (100-count units). This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive process and scheduled for completion by October 20, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....